Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
lenvatinib
E7080-J081-103
NCT00280397
Solid Tumors
Phase 1
 
Analysis and reporting datasets are not CDISC compliant and contain labelling in English and Japanese. Note: Japan is the only country participating in this study.
September 2015

Powered by ideaPoint, Inc.